Displaying 25 - 36 of 49
Metabolism, Alcohol & Toxicity

System-based solutions for NAFLD in the UK

Webcasts
View
Metabolism, Alcohol & Toxicity

Current landscape of Non-invasive technologies and the Role of LiverMultiScan Quantitative Multiparametric MRI for Patient Ris...

Webcasts
View
Metabolism, Alcohol & Toxicity

Upcoming NASH Therapeutics; The Need for Non-Invasive Technologies

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introductions

Webcasts
View
Metabolism, Alcohol & Toxicity

Diagnosis of HRS-AKI

Webcasts
View
Metabolism, Alcohol & Toxicity

Advances in the Management of HRS-AKI

Webcasts
View
Metabolism, Alcohol & Toxicity

Application to practice: Case studies

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion and Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Webcasts
View
Metabolism, Alcohol & Toxicity

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Why do we need to manage obesity in NAFLD/NASH?

Webcasts
View